{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T04:08:10Z","timestamp":1749701290455,"version":"3.41.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1997,3,1]],"date-time":"1997-03-01T00:00:00Z","timestamp":857174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1997,3,1]],"date-time":"1997-03-01T00:00:00Z","timestamp":857174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[1997,3]]},"DOI":"10.1023\/a:1005771717409","type":"journal-article","created":{"date-parts":[[2002,12,21]],"date-time":"2002-12-21T23:13:52Z","timestamp":1040512432000},"page":"29-38","source":"Crossref","is-referenced-by-count":7,"title":["Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. II. Cytokine production and in vivo efficacy of glioma-sensitized lymphocytes"],"prefix":"10.1007","volume":"32","author":[{"given":"Charles D.","family":"Rice","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nevan G.","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland T.","family":"Biron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry D.","family":"Bear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall E.","family":"Merchant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"116921_CR1","first-page":"94","volume":"13","author":"DE Bullard","year":"1986","unstructured":"Bullard DE, Gillespie GY, Mahaley MS, Bigner DD: Immunobiology of gliomas. Sem Oncol 13: 94\u2013109, 1986","journal-title":"Sem Oncol"},{"key":"116921_CR2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00177842","volume":"8","author":"RE Merchant","year":"1990","unstructured":"Merchant RE, Ellison MD, Young HF: Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes. A review of pre-clinical and clinical investigations. J Neuro-Oncol 8: 173\u2013188, 1990","journal-title":"J Neuro-Oncol"},{"key":"116921_CR3","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1227\/00006123-198812000-00007","volume":"23","author":"RE Merchant","year":"1988","unstructured":"Merchant RE, Merchant LH, Cook SHS, McVicar DW, Young HF: Intralesional infusion of lymphokine-activated killer (LAK) cells and recombinant interleukin-2 (rIL-2) for the treatment of patients with malignant brain tumor. Neurosurgery 23: 725\u2013732, 1988","journal-title":"Neurosurgery"},{"key":"116921_CR4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF01741334","volume":"32","author":"EA Grimm","year":"1991","unstructured":"Grimm EA, Brunner JM, Carinhas J, Koppen JA, Loudon WG, Owen-Schaub L, Steck PA, Moser RP: Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: growth characteristics, cytolytic activity, and cell phenotype. Cancer Immunol Immunother 32: 391\u2013399, 1991","journal-title":"Cancer Immunol Immunother"},{"key":"116921_CR5","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1227\/00006123-199209000-00015","volume":"31","author":"FP Holladay","year":"1992","unstructured":"Holladay FP, Heitz T, Chen YL, Chiga M, Wood GW: Successful treatment of malignant rat glioma with cytotoxic Tlymphocytes. Neurosurgery 31: 528\u2013533, 1992","journal-title":"Neurosurgery"},{"key":"116921_CR6","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1227\/00006123-198606000-00015","volume":"18","author":"JT Paine","year":"1986","unstructured":"Paine JT, Janda H, Yamasaki T, Yamashita J, Miyatake S: Immunohistochemical analysis of infiltrating lymphocytes in central nervous system tumors. Neurosurgery 18: 766\u2013772, 1986","journal-title":"Neurosurgery"},{"key":"116921_CR7","first-page":"1843","volume":"49","author":"Y Sawamura","year":"1989","unstructured":"Sawamura Y, Hosokawa M, Kuppner, Kobayashi H, Aida T, Abe H, de Tribolet N: Antitumor activity and surface phenotypes of human glioma-infiltrating lymphocytes after in vitroexpansion in the presence of interleukin 2. Cancer Res 49: 1843\u20131849, 1989","journal-title":"Cancer Res"},{"key":"116921_CR8","doi-asserted-by":"crossref","first-page":"9577","DOI":"10.1073\/pnas.87.24.9577","volume":"87","author":"CA Kruse","year":"1990","unstructured":"Kruse CA, Lillehei KO, Mitchell DH, Kleinschmidt-De-Masters B, Bellgrau D: Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L gliosarcoma: Allogeneic cytotoxic T lymphocytes prevent tumor take. Proc Nat Acad Sci USA 87: 9577\u20139581, 1990","journal-title":"Proc Nat Acad Sci USA"},{"key":"116921_CR9","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF01741557","volume":"34","author":"JM Redd","year":"1992","unstructured":"Redd JM, Lagarde A-C, Kruse CA, Bellgrau D: Allogeneic tumor-specific cytotoxic T lymphocytes. Cancer Immunol Immunother 34: 349\u2013354, 1992","journal-title":"Cancer Immunol Immunother"},{"key":"116921_CR10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3171\/jns.1994.80.1.0090","volume":"80","author":"FP Holladay","year":"1994","unstructured":"Holladay FP, Choudhuri R, Heitz T, Wood GW: Generation of cytotoxic immune responses during the progression of a rat glioma. J Neurosurg 80: 90\u201396, 1994","journal-title":"J Neurosurg"},{"key":"116921_CR11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-5728(93)90264-Y","volume":"44","author":"FP Holladay","year":"1993","unstructured":"Holladay FP, Wood GW: Generation of cellular immune responses against a glioma-associated antigen(s). J Neuroimmunol 44: 27\u201332, 1993","journal-title":"J Neuroimmunol"},{"key":"116921_CR12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0022-1759(91)90380-X","volume":"140","author":"RJ Barth","year":"1991","unstructured":"Barth RJ, Mule JJ, Asher AL, Sanda MG, Rosenberg SA: Identification of unique murine tumor associated antigens by tumor infiltrating lymphocytes using tumor specific secretion of interferon-??and tumor necrosis factor. J Immunol Method 140: 269\u2013279, 1991","journal-title":"J Immunol Method"},{"key":"116921_CR13","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/00002371-199112000-00003","volume":"10","author":"F Jotereau","year":"1991","unstructured":"Jotereau F, Pandolfino MC, Boudart D, Diez E, Dreno B, Douillard JY, Muller JY, LeMevel B: High-fold expansion of human cytotoxic T-lymphocytes specific for autologous melanoma cells for use in immunotherapy. J Immunother 10: 404\u2013411, 1991","journal-title":"J Immunother"},{"key":"116921_CR14","first-page":"2372","volume":"51","author":"JJ Tzeng","year":"1991","unstructured":"Tzeng JJ, Barth RF, Orosz CG, James SM: Phenotype and functional activity of tumor-infiltrating lymphocytes isolated from immunogenic and nonimmunogenic rat brain tumors. Cancer Res 51: 2372\u20132378, 1991","journal-title":"Cancer Res"},{"key":"116921_CR15","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.4049\/jimmunol.146.12.4414","volume":"146","author":"KD Crossland","year":"1991","unstructured":"Crossland KD, Lee VK, Chen W, Riddell SR, Greenberg PD, Cheever MA: T-cells from tumor-immune mice nonspecifically expanded in vitrowith anti-CD3 plus IL-2 retain specific function in vitroand can eradicate disseminated leukemia in vivo. J Immunol 146: 4414\u20134420, 1991","journal-title":"J Immunol"},{"key":"116921_CR16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF01741708","volume":"32","author":"EWP Nijhuis","year":"1990","unstructured":"Nijhuis EWP, Kemenade EW, Figdor CG, Van Lier RAW: Activation and expansion of tumor-infiltrating lymphocytes by anti-CD3 and anti-CD28 monoclonal antibodies. Cancer Immunol Immunother 32: 245\u2013250, 1990","journal-title":"Cancer Immunol Immunother"},{"key":"116921_CR17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0022-1759(90)90303-D","volume":"130","author":"JR Yanelli","year":"1990","unstructured":"Yanelli JR, Crumpacker DB, Good RW, Friddell CD, Poston R, Horton S, Maleckar JR, Oldham RK: Use of anti-CD3 monoclonal antibody in the generation of effector cells from human solid tumors for use in cancer biotherapy. J Immunol Methods 130: 91\u2013100, 1990","journal-title":"J Immunol Methods"},{"key":"116921_CR18","first-page":"548","volume":"52","author":"TM Tuttle","year":"1992","unstructured":"Tuttle TM, Inge TH, Bethke KP, McCrady CW, Pettit GR, Bear HD: Activation and growth of murine tumor-specific T-cells which have in vivoactivity with Bryostatin-1. Cancer Res 52: 548\u2013553, 1992","journal-title":"Cancer Res"},{"key":"116921_CR19","first-page":"833","volume":"53","author":"TM Tuttle","year":"1993","unstructured":"Tuttle TM, McCrady CW, Igge TH, Mozhdeh S, Bear HD: ?-interferon plays a key role in T-cell-induced tumor regression. Cancer Res 53: 833\u2013839, 1993","journal-title":"Cancer Res"},{"key":"116921_CR20","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1073\/pnas.83.5.1334","volume":"83","author":"AS Kraft","year":"1986","unstructured":"Kraft AS, Smith JB, Berkow RL: Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester induced differentiation of human promyelocytic progenitor cells HL-60. Proc Natl Acad Sci USA 83: 1334\u20131338, 1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"116921_CR21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jso.2930460210","volume":"46","author":"SK Hoover","year":"1991","unstructured":"Hoover SK, Frank JL, McCrady CW, McKinnon JG, Bear HD: Activation and in vitroexpansion of tumor-reactive T lymphocytes from lymph nodes draining human primary breast cancers. J Surg Oncol 46: 117\u2013124, 1991","journal-title":"J Surg Oncol"},{"key":"116921_CR22","unstructured":"Baldwin NB, Rice CD, Tuttle TM, Bear HD, Hirsch JI, Merchant RE: Ex vivoexpansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. I. Characterization and in vivoanti-tumor activity of glioma-sensitized lymphocytes. J Neuro-Oncol, in press, 1996"},{"key":"116921_CR23","unstructured":"Merchant RE, Baldwin NB, Rice CD, Bear HD: Adoptive immunotherapy of malignant glioma using tumor-sensitized T lymphocytes. Neurol Res, in press, 1995"},{"key":"116921_CR24","doi-asserted-by":"crossref","unstructured":"Elswick RK, Chinchilli V: A mixture of the MANOVA and GMNOVA models. Commun Statist 14: 3075\u20133089","DOI":"10.1080\/03610928508829096"},{"key":"116921_CR25","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/jnci\/80.13.999","volume":"80","author":"JR Ortaldo","year":"1988","unstructured":"Ortaldo JR, Longo DL: Human natural lymphocytic effector cells: Definition, analysis of activity, and clinical effectiveness. JNCI 80: 999\u20131010, 1988","journal-title":"JNCI"},{"key":"116921_CR26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.153.3.569","volume":"153","author":"T Timonen","year":"1981","unstructured":"Timonen T, Ortaldo JR, Herberman RB: Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med 153: 569\u2013582, 1981","journal-title":"J Exp Med"},{"key":"116921_CR27","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJM199008303230904","volume":"323","author":"SA Rosenberg","year":"1990","unstructured":"Rosenberg SA, Lotze MT, Yang JC, Topalian SL, Merino MJ, Culver K, Miller AD, Blaese RM, Anderson WF: Gene transfer into humans\u2013immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 323: 570\u2013578, 1990","journal-title":"N Engl J Med"},{"key":"116921_CR28","first-page":"5765","volume":"47","author":"MD Ellison","year":"1987","unstructured":"Ellison MD, Povlishock JT, Merchant RE: Blood-brain barrier dysfunction in cats following recombinant interleukin-2 infusion. Cancer Res 47: 5765\u20135770, 1987","journal-title":"Cancer Res"},{"key":"116921_CR29","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4049\/jimmunol.137.5.1735","volume":"137","author":"M Rosenstein","year":"1986","unstructured":"Rosenstein M, Ettinghausen SE, Rosenberg SA: Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin-2. J Immunol 137: 1735\u20131742, 1986","journal-title":"J Immunol"},{"key":"116921_CR30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1227\/00006123-198908000-00008","volume":"25","author":"RG Watts","year":"1989","unstructured":"Watts RG, Wright JL, Atkinson LL, Merchant RE: Histopathological and blood-brain barrier changes in rats induced by intracerebral injection of human recombinant interleukin-2. Neurosurgery 25: 202\u2013208, 1989","journal-title":"Neurosurgery"},{"key":"116921_CR31","first-page":"93","volume":"29","author":"IH Ames","year":"1989","unstructured":"Ames IH, Gagne GM, Garcia AM, John PA, Scatorchia GM, Tomar RH, McAfee JG: Preferential homing of tumor-infiltrating lymphocytes in tumor-bearing mice. Cancer Immunol Immunother 29: 93\u2013100, 1989","journal-title":"Cancer Immunol Immunother"},{"key":"116921_CR32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ijc.2910440205","volume":"44","author":"DD Schoof","year":"1989","unstructured":"Schoof DD, Jung SE, Eberlein TJ: Human tumor-infiltrating lymphocyte (TIL) cytotoxicity facilitated by anti-T-cell receptor antibody. Int J Cancer 44: 219\u2013224, 1989","journal-title":"Int J Cancer"},{"key":"116921_CR33","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.4049\/jimmunol.140.7.2453","volume":"140","author":"T Chou","year":"1988","unstructured":"Chou T, Chang A, Shu S: Generation of therapeutic T lymphocytes from tumor bearing mice by in vitrosensitization. Culture requirements and characterization of immunospecificity. J Immunol 140: 2453\u20132461, 1988","journal-title":"J Immunol"},{"key":"116921_CR34","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/eji.1830200417","volume":"20","author":"N Gervois","year":"1990","unstructured":"Gervois N, Heuze F, Diez E, Jotereau F: Selective expansion of specific anti-tumor CD8+ cytotoxic T-lymphocyte clones in bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T-cell receptor gene rearrangements. Eur J Immunol 20: 825\u2013831, 1990","journal-title":"Eur J Immunol"},{"key":"116921_CR35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00205232","volume":"28","author":"DL Hines","year":"1989","unstructured":"Hines DL: Failure of specific adoptive immunotherapy owing to survival and outgrowth of variant cells. Cancer Immunol Immunother 28: 241\u2013247, 1989","journal-title":"Cancer Immunol Immunother"},{"key":"116921_CR36","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/archsurg.1993.01420230109017","volume":"128","author":"AE Chang","year":"1993","unstructured":"Chang AE, Geiger JD, Sondak VK, Shu S: Adoptive cellular therapy of malignancy. Arch Surg 128: 1281\u20131290, 1993","journal-title":"Arch Surg"},{"key":"116921_CR37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00002371-199311000-00005","volume":"14","author":"S Shu","year":"1993","unstructured":"Shu S, Sussman JJ, Chang AE: In vivoantitumor efficacy of tumor-draining lymph node cells activated with nonspecific T-cell reagents. J Immunother 14: 279\u2013285, 1993","journal-title":"J Immunother"},{"key":"116921_CR38","first-page":"43","volume":"13","author":"CD Rice","year":"1992","unstructured":"Rice CD, Merchant RE: Systemic treatment with murine recombinant interleukin-1??inhibits the growth and progression of malignant glioma in the rat. J Neuro-Oncol 13: 43\u201355, 1992","journal-title":"J Neuro-Oncol"},{"key":"116921_CR39","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.4049\/jimmunol.140.10.3450","volume":"140","author":"TL Gerrard","year":"1988","unstructured":"Gerrard TL, Dyer DR, Zoom KC, Nedden DZ, Siegel JP: Modulation of class I and class II histocompatibility antigens on human T cell lines by IFN-?. J Immunol 140: 3450\u20133455, 1988","journal-title":"J Immunol"},{"key":"116921_CR40","doi-asserted-by":"crossref","first-page":"788","DOI":"10.4049\/jimmunol.131.2.788","volume":"131","author":"GHW Wong","year":"1983","unstructured":"Wong GHW, Clark-Lewis I, McKimm-Breschkin JL, Harris AW, Schrader JW: Interferon-??induces enhanced expression of Ia and H-2 antigen on lymphoid, macrophage, and myeloid cell lines. J Immunol 131: 788\u2013793, 1983","journal-title":"J Immunol"},{"key":"116921_CR41","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.4049\/jimmunol.135.4.2287","volume":"135","author":"DC Flyer","year":"1985","unstructured":"Flyer DC, Burakoff SJ, Faller DV: Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes. J Immunol 135: 2287\u20132292, 1985","journal-title":"J Immunol"},{"key":"116921_CR42","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.4049\/jimmunol.130.4.1784","volume":"130","author":"T Kasahara","year":"1983","unstructured":"Kasahara T, Hooks JJ, Dougherty SF, Oppenheim JJ: Interleukin-2 mediated immune interferon (IFN-?) production by human T cells and T cell subsets. J Immunol 130: 1784\u20131789, 1983","journal-title":"J Immunol"},{"key":"116921_CR43","first-page":"2001","volume":"130","author":"JL Place","year":"1983","unstructured":"Place JL, Russel SW, Torres BA, Johnson HM, Gray PW: Recombinant mouse ?-interferon induces the prime step in macrophage activation for tumor cell killing. J Immunol 130: 2001\u20132013, 1983","journal-title":"J Immunol"},{"key":"116921_CR44","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.4049\/jimmunol.141.8.2831","volume":"141","author":"M Giovarelli","year":"1988","unstructured":"Giovarelli M, Santoni A, Jemma C, Musso T, Ginffrida AM, Cavallo G, Landofo S, Forni G: Obligatory role of IFN-??in induction of lymphokine-activated and T-lymphocyte killer, but not in boosting of natural cytotoxicity. J Immunol 141: 2831\u20132836, 1988","journal-title":"J Immunol"},{"key":"116921_CR45","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/jnci\/82.3.217","volume":"82","author":"S Miyatake","year":"1990","unstructured":"Miyatake S, Nishihara K, Kikuchi H, Yamashita J, Namba Y, Hanaoka M, Watanabe Y: Efficient tumor suppression by glioma-specific murine cytotoxic T lymphocytes transfected with interferon-??gene. JNCI 82: 217\u2013220, 1990","journal-title":"JNCI"},{"key":"116921_CR46","first-page":"4730","volume":"48","author":"K Nishihara","year":"1988","unstructured":"Nishihara K, Miyatake K, Sakata T, Yamashita J, Kikuchi H, Kawade Y, Zu Y, Namba Y, Hanoka M, Watanabe Y: Augmentation of tumor targeting in a line of glioma-specific mouse cytotoxic T-lymphocytes by retroviral expression of mouse ?-IFN complementary DNA. Cancer Res 48: 4730\u20134735, 1988","journal-title":"Cancer Res"},{"key":"116921_CR47","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1084\/jem.164.4.1206","volume":"164","author":"G Trinchieri","year":"1986","unstructured":"Trinchieri G, Kobayashi M, Rosen M, Loudon R, Murphy M, Perussia B: Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon. J Exp Med 164: 1206\u20131225, 1986","journal-title":"J Exp Med"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1005771717409.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1005771717409\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1005771717409.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T08:34:16Z","timestamp":1749630856000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1005771717409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,3]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,3]]}},"alternative-id":["116921"],"URL":"https:\/\/doi.org\/10.1023\/a:1005771717409","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[1997,3]]}}}